Patients undergoing surgery in ambulatory surgery centers are safer than those who undergo procedures in doctors' offices, although the relative risk of death or injury is low in both types of facilities, a new Florida study indicates.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.